The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome

JC Lega, N Fabien, Q Reynaud, I Durieu, S Durupt… - Autoimmunity …, 2014 - Elsevier
Objective To describe the clinical spectrum associated with aminoacyl-transfer RNA synthetase
(ARS) autoantibodies in patients with idiopathic inflammatory myositis defined according …

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta …

Q Reynaud, JC Lega, P Mismetti, C Chapelle… - Autoimmunity …, 2014 - Elsevier
… Author links open overlay panel Quitterie Reynaud a , Jean-Christophe Lega b c , Patrick
Mismetti c d e , Céline Chapelle d f , Denis Wahl g h , Pascal Cathébras a , Silvy Laporte c d f …

Idiopathic inflammatory myopathies and the lung

JC Lega, Q Reynaud, A Belot, N Fabien… - European …, 2015 - Eur Respiratory Soc
Idiopathic inflammatory myositis (IIM) is a group of rare connective tissue diseases (CTDs)
characterised by muscular and extramuscular signs, in which lung involvement is a …

Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies

Q Reynaud, I Durieu, M Dutertre, S Ledochowski… - Autoimmunity …, 2015 - Elsevier
Objective This study aims to evaluate the response to rituximab (RTX) treatment in auto-immune
hemolytic anemia (AIHA) patients. Methods Studies were selected from MEDLINE up to …

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis

…, S Provencher, I Durieu, S Jardel, A Hot, Q Reynaud… - Autoimmunity …, 2019 - Elsevier
Objective Interstitial lung disease (ILD) is the most severe complication of idiopathic inflammatory
myositis (IIM), resulting in significant increase in morbidity and mortality and for which …

Prevalence of giant cell arteritis relapse in patients treated with glucocorticoids: a meta‐analysis

…, M Cucherat, I Durieu, Q Reynaud… - Arthritis care & …, 2020 - Wiley Online Library
Objective The relapse rate of patients with giant cell arteritis ( GCA ) treated with glucocorticoids
( GC s) alone varied widely in observational series and randomized controlled trials ( …

[HTML][HTML] Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

B Misgault, E Chatron, Q Reynaud, S Touzet… - Journal of Cystic …, 2020 - Elsevier
Objectives To investigate the effects of 1-year lumacaftor–ivacaftor treatment on abnormalities
in glucose tolerance (AGT) in Phe508del homozygous cystic fibrosis (CF) patients. …

[HTML][HTML] Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2 years of treatment with ivacaftor in a …

…, S Ramel, ID Boucher, S Lefeuvre, Q Reynaud… - Journal of Cystic …, 2018 - Elsevier
Background Ivacaftor has been shown to improve lung function and body weight in patients
with CF and a gating mutation. Real-world evaluation is warranted to examine its safety and …

Evaluation of rituximab for induction and maintenance therapy in patients 75 years and older with antineutrophil cytoplasmic antibody–associated vasculitis

…, HN Rakotoarivelo, A Régent, Q Reynaud… - JAMA Network …, 2022 - jamanetwork.com
Importance Older patients are underrepresented in studies of rituximab for the treatment of
antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. Little is known about …

Reproductive health after thoracic transplantation: an ISHLT expert consensus statement

…, LR Punnoose, KD Rasmusson, Q Reynaud… - The Journal of Heart and …, 2023 - Elsevier
Pregnancy after thoracic organ transplantation is feasible for select individuals but requires
multidisciplinary subspecialty care. Key components for a successful pregnancy after lung or …